Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.
See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.
Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.
Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.
Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.

| TITLE/ COMPANY | Issue Date | Status | Details |
|---|---|---|---|
| Your facility is not maintained in a good state of repair, creating insanitary conditions whereby drug products may be contaminated with filth. Pharmaneek Inc |
08 Apr 2026 | Normal | Justification: Environmental Monitoring is integral in ensuring that the control room environment remains free from contaminants that could affect product safety. Excerpt: A ceiling tile in the control room was observed to be chipped, with part missing, exposing the room to environmental contaminants. View Details |
| Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed. Grifols Diagnostic Solutions |
13 Mar 2026 | Normal | Justification: Environmental Monitoring is directly linked to detecting contamination, mentioned in observation part B. Excerpt: The environmental monitoring program was inadequate in identifying and acting on potential sources of contamination in the aseptic processing area. View Details |
| Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed. EUGIA Pharma Specialities Limited |
27 Feb 2026 | Normal | Justification: Environmental Monitoring is involved as the critical operation area failed to adhere to Grade A-No Growth standards. Excerpt: The area is not held to Grade A classification during this critical operation. View Details |
| Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established. Maiva Pharma Private Limited |
20 Feb 2026 | Normal | Justification: Environmental Monitoring is linked as it is crucial to ensure sterile conditions which are affected by AHU performance. Excerpt: Failure to establish adequate procedural controls for AHU shutdown and restart may result in loss of pressure cascade ... View Details |
| Aseptic processing areas are deficient regarding the system for monitoring environmental conditions. Maiva Pharma Private Limited |
20 Feb 2026 | Normal | Justification: Inadequate environmental controls identified highlight deficiencies specifically in Environmental Monitoring protocols. Excerpt: Your firm failed to provide a scientific rationale for performing environmental monitoring under either static or dynamic conditions without defined criteria. View Details |
View and learn more about FDA Inspections
with our comprehensive list of resources